SAN FRANCISCO (GenomeWeb) – Interest continues to grow to use metagenomic sequencing as a clinical infectious disease test, given its potential to be fast and agnostic. Last month, researchers from the University of East Anglia's Quadram Institute Bioscience described a nanopore metagenomic sequencing approach for diagnosing lower respiratory illness in a publication on the BioRxiv preprint server.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.